Is Jazz Pharmaceuticals Stock a Buy?

In February, biotech company Jazz Pharmaceuticals(NASDAQ:JAZZ) made some noise when it announced it would acquire GW Pharmaceuticals, a drugmaker specializing in developing cannabidiol (CBD)-derived medicines. The cash-and-stock transaction, which closed…

Click here to view the original article.